As Africa’s disease burden shifts, access to essential medicines is emerging as an even bigger challenge. A new report launched by the Access to Medicine Foundation has spotlighted how generic medicine manufacturers are responding to rising demand for treatments, particularly for diabetes, cardiovascular diseases and cancer, while warning that only one in two people living with type 1 diabetes on the continent has reliable access to insulin. Chiemelie Ezeobi reports

Africa’s struggle to make essential medicines affordable is not simply a problem of inadequate pharmaceutical production, as a new…

As Africa’s disease burden shifts, access to essential medicines is emerging as an even bigger challenge. A new report launched by the Access to Medicine Foundation has…